1. Home
  2. NTST vs RCUS Comparison

NTST vs RCUS Comparison

Compare NTST & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTST
  • RCUS
  • Stock Information
  • Founded
  • NTST 2019
  • RCUS 2015
  • Country
  • NTST United States
  • RCUS United States
  • Employees
  • NTST N/A
  • RCUS N/A
  • Industry
  • NTST Real Estate Investment Trusts
  • RCUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTST Real Estate
  • RCUS Health Care
  • Exchange
  • NTST Nasdaq
  • RCUS Nasdaq
  • Market Cap
  • NTST 1.2B
  • RCUS 1.2B
  • IPO Year
  • NTST 2020
  • RCUS 2018
  • Fundamental
  • Price
  • NTST $15.00
  • RCUS $9.53
  • Analyst Decision
  • NTST Strong Buy
  • RCUS Strong Buy
  • Analyst Count
  • NTST 7
  • RCUS 11
  • Target Price
  • NTST $17.75
  • RCUS $31.78
  • AVG Volume (30 Days)
  • NTST 1.0M
  • RCUS 1.4M
  • Earning Date
  • NTST 04-28-2025
  • RCUS 05-07-2025
  • Dividend Yield
  • NTST 5.57%
  • RCUS N/A
  • EPS Growth
  • NTST N/A
  • RCUS N/A
  • EPS
  • NTST N/A
  • RCUS N/A
  • Revenue
  • NTST $162,784,000.00
  • RCUS $258,000,000.00
  • Revenue This Year
  • NTST N/A
  • RCUS N/A
  • Revenue Next Year
  • NTST $9.61
  • RCUS $28.07
  • P/E Ratio
  • NTST N/A
  • RCUS N/A
  • Revenue Growth
  • NTST 23.41
  • RCUS 120.51
  • 52 Week Low
  • NTST $13.42
  • RCUS $9.01
  • 52 Week High
  • NTST $18.97
  • RCUS $19.18
  • Technical
  • Relative Strength Index (RSI)
  • NTST 57.38
  • RCUS 35.97
  • Support Level
  • NTST $14.68
  • RCUS $9.01
  • Resistance Level
  • NTST $15.71
  • RCUS $10.03
  • Average True Range (ATR)
  • NTST 0.40
  • RCUS 0.70
  • MACD
  • NTST 0.03
  • RCUS 0.05
  • Stochastic Oscillator
  • NTST 53.90
  • RCUS 19.48

About NTST NetSTREIT Corp.

Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: